Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 12BRISTOL MYERS SQUIBB

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

ENASIDENIB MESYLATE

US Patent Number : 9512107

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209606

Patent Use Code : U-2087

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-01-07

blank

02

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

ENASIDENIB MESYLATE

US Patent Number : 9512107

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209606

Patent Use Code : U-2087

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-01-07

blank

03

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

ENASIDENIB MESYLATE

US Patent Number : 10093654

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209606

Patent Use Code : U-2087

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-08-01

blank

04

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

ENASIDENIB MESYLATE

US Patent Number : 10093654

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209606

Patent Use Code : U-2087

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-08-01

blank

05

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

ENASIDENIB MESYLATE

US Patent Number : 10294215

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209606

Patent Use Code : U-2087

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-01-07

blank

06

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

ENASIDENIB MESYLATE

US Patent Number : 10294215

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209606

Patent Use Code : U-2087

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-01-07

blank

07

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

ENASIDENIB MESYLATE

US Patent Number : 10610125

Drug Substance Claim :

Drug Product Claim :

Application Number : 209606

Patent Use Code : U-2087

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-06-21

blank

08

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

ENASIDENIB MESYLATE

US Patent Number : 10610125

Drug Substance Claim :

Drug Product Claim :

Application Number : 209606

Patent Use Code : U-2087

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-06-21

blank

09

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

ENASIDENIB MESYLATE

US Patent Number : 9732062

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 209606

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-09-16

blank

10

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

ENASIDENIB MESYLATE

US Patent Number : 9738625

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 209606

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-08-01

blank